相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia
Zdenek Racil et al.
HEMATOLOGICAL ONCOLOGY (2014)
The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia
Filip Razga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Assessment of adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) mRNA expression in patients with de novo chronic myelogenous leukemia: the role of different cell types
Zdenek Racil et al.
LEUKEMIA & LYMPHOMA (2011)
The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population
Zdenek Racil et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
Deborah L. White et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia
L. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
Stephane Picard et al.
BLOOD (2007)
分享论文
